Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001641172-25-024017·Korsana Biosciences, Inc.
Schedule 13G ownership disclosure
CYCLERION THERAPEUTICS INC
Common Stock, no par value · CUSIP: 23255M204
Event date: 2025-06-30
- Filing-level shares
- 155,187.00
- Percent of class
- 4.8%
- Tyndall Capital Partners, L.P.
Shares: 155,187.00 · Class: 4.8%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001641172-25-024017
- Form type
- SCHEDULE 13G/A
- Filer
- Korsana Biosciences, Inc.
- CIK
- CIK 1755237
- Filed
- Aug 14, 2025
- Reporting period
- Jun 30, 2025
- Description
- Schedule 13G beneficial ownership